BPTSY · Biophytis S.A.

Biophytis SA announced the postponement of its annual financial statements for the year ended December 31, 2025, originally due by April 30, 2026. The delay is attributed to the company's focus on a €2.015 million refinancing transaction, which required substantial management attention and negotiations. As a result, the company needs additional time to finalize closing procedures and complete the statutory audit. Biophytis now expects to publish the financial statements by the end of May 2026. This postponement may raise concerns among investors regarding the company's financial health and operational capacity, though the refinancing effort suggests active management of liquidity. The delay is a material event as it affects the timely disclosure of financial performance and could impact investor confidence and stock liquidity.